AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.8267
-0.0719 (-8.00%)
At close: Jun 2, 2026, 4:00 PM EDT
0.7146
-0.1121 (-13.56%)
Pre-market: Jun 3, 2026, 8:34 AM EDT
AIM ImmunoTech Employees
As of December 31, 2025, AIM ImmunoTech had 21 total employees, including 19 full-time and 2 part-time employees. The number of employees decreased by 2 or -8.70% compared to the previous year.
Employees
21
Change (1Y)
-2
Growth (1Y)
-8.70%
Revenue / Employee
$4,476
Profits / Employee
-$632,190
Market Cap
13.01M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 21 | -2 | -8.70% | 19 | 2 |
| Dec 31, 2024 | 23 | -5 | -17.86% | 21 | 2 |
| Dec 31, 2023 | 28 | 4 | 16.67% | 26 | 2 |
| Dec 31, 2022 | 24 | 1 | 4.35% | 22 | 2 |
| Dec 31, 2021 | 23 | 0 | - | 21 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 42 |
| HCW Biologics | 35 |
| Lunai Bioworks | 29 |
| Moleculin Biotech | 17 |
| Theriva Biologics | 16 |
| CalciMedica | 16 |
| BioVie | 13 |
| Phio Pharmaceuticals | 6 |
AIM News
- 18 hours ago - 3 Penny Stocks Drawing Market Attention, 6/2/26 - TipRanks
- 1 day ago - AIM ImmunoTech enrolls final subject in pancreatic cancer development program - TheFly
- 1 day ago - AIM ImmunoTech Completes Phase 2 DURIPANC Enrollment Milestone Ahead of Schedule, Advancing Ampligen Toward Critical Pancreatic Cancer Clinical Milestones - GlobeNewsWire
- 6 days ago - AIM ImmunoTech Announces Emerging Ebola Opportunity for Ampligen Amid Escalating Global Health Concerns and WHO Emergency Declaration - GlobeNewsWire
- 13 days ago - AIM ImmunoTech Inc trading resumes - TheFly
- 13 days ago - AIM ImmunoTech announces $2.4M registered direct offering - TheFly
- 13 days ago - AIM ImmunoTech Announces $2.4 Million Financing, Including Concurrent Registered Direct Offering and Private Placement - GlobeNewsWire
- 13 days ago - AIM ImmunoTech Inc trading halted, news pending - TheFly